Literature DB >> 8537634

Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase.

V V Rao1, D C Anthony, D Piwnica-Worms.   

Abstract

Multidrug resistance (MDR) is associated with overexpression of a 170 KD plasma membrane P-glycoprotein (P-gp), a putative energy-dependent efflux transporter that reduces intracellular accumulation of chemotherapeutic agents. For detection of P-gp expression in normal and malignant tissues, an MDR1-specific monoclonal antibody (MAb) JSB-1 has been used extensively. In this report we show that MAb JSB-1 crossreacts with a protein of M(r) approximately 130,000 present in rat liver mitochondrial inner membrane/matrix fractions. Peptide mapping and microsequencing identify this protein as pyruvate carboxylase (PC), an abundant mitochondrial enzyme. MAb JSB-1 also crossreacts with purified PC from bovine liver. Under immunoblotting conditions, this crossreactivity is partially abolished by pre-incubation of MAb JSB-1 with a 1000-fold molar excess of MAb C494 epitope-specific peptide (PNTLEGN), indicating that the epitope of MAb JSB-1 may either overlap with or be in close proximity to that of MAb C494. Immunohistochemical cross-reactivity was also demonstrated in cryosections of human skeletal muscle, a tissue known not to express P-gp. MAb JSB-1 strongly immunostained Type 1 fibers, the subtype known to contain abundant mitochondria. Use of MAb JSB-1 for detection of MDR1 P-gp expression should be approached with caution.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537634     DOI: 10.1177/43.12.8537634

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  6 in total

1.  Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity.

Authors:  Li Wei; Fan Dongmei; Yang Ming; Shi Ruizan; Yan Yan; Jiang Linlin; Yan Cihui; Li Shuangjing; Wang Min; Wang Jianxiang; Xiong Dongsheng
Journal:  Cell Oncol (Dordr)       Date:  2012-10-09       Impact factor: 6.730

2.  Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression.

Authors:  X Y Mu; M P Gosland; M M Bartik; J Schimmelpfennig; N E Kay
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

3.  Human brain tumors: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.

Authors:  Silvia Fattori; Francesca Becherini; Maurizio Cianfriglia; Giuliano Parenti; Antonella Romanini; Maura Castagna
Journal:  Virchows Arch       Date:  2007-06-26       Impact factor: 4.064

4.  The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta cells is mediated by a 65-kDa mdr-like P-glycoprotein.

Authors:  S Barg; E Renström; P O Berggren; A Bertorello; K Bokvist; M Braun; L Eliasson; W E Holmes; M Köhler; P Rorsman; F Thévenod
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

5.  Quantitative analysis of multidrug-resistance mdr1 gene expression in head and neck cancer by real-time RT-PCR.

Authors:  Ching-Ping Tseng; Ann-Joy Cheng; Joseph Tung-Chieh Chang; Chin-Hsiao Tseng; Hung-Ming Wang; Chun-Ta Liao; I-How Chen; Kelvin Chingchung Tseng
Journal:  Jpn J Cancer Res       Date:  2002-11

6.  P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury.

Authors:  Sydney M Vita; John B Redell; Mark E Maynard; Jing Zhao; Raymond J Grill; Pramod K Dash; Bernadette E Grayson
Journal:  Neurotrauma Rep       Date:  2020-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.